Related references
Note: Only part of the references are listed.CSF α-synuclein correlates with CSF neurogranin in late-life depression
Davide Bruno et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)
Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders A Meta-analysis
Ioannis Mavroudis et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2020)
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
M. van de Beek et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study
Martina Azar et al.
ALZHEIMERS & DEMENTIA (2020)
Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson's Disease Patients and Is Present within Lewy Bodies
Madhurima Chatterjee et al.
BIOMOLECULES (2020)
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Inger van Steenoven et al.
MOLECULAR NEURODEGENERATION (2020)
Multiscale causal networks identify VGF as a key regulator of Alzheimer's disease
Noam D. Beckmann et al.
NATURE COMMUNICATIONS (2020)
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome
Olivia Belbin et al.
MOLECULAR NEURODEGENERATION (2020)
Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study
Brit Mollenhauer et al.
JOURNAL OF NEUROCHEMISTRY (2019)
α-Synuclein: A Multifunctional Player in Exocytosis, Endocytosis, and Vesicle Recycling
Mingzhu Huang et al.
FRONTIERS IN NEUROSCIENCE (2019)
The physiological role of α-synuclein and its relationship to Parkinson's Disease
David Sulzer et al.
JOURNAL OF NEUROCHEMISTRY (2019)
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Inger van Steenoven et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults
Anja Soldan et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease
Gajanan Sathe et al.
PROTEOMICS CLINICAL APPLICATIONS (2019)
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease
Marta Mila-Aloma et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
Douglas Galasko et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Cell Biology and Pathophysiology of α-Synuclein
Jacqueline Burre et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease
Edward J. Goetzl et al.
FASEB JOURNAL (2018)
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease
Flora H. Duits et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Lewy Body Dementia
Angela M. Sanford
CLINICS IN GERIATRIC MEDICINE (2018)
α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
Inger van Steenoven et al.
MOVEMENT DISORDERS (2018)
Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results
Betty M. Tijms et al.
CLINICAL CHEMISTRY (2018)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia
Davide Chiasserini et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
NPTX2 and cognitive dysfunction in Alzheimers Disease
Mei-Fang Xiao et al.
ELIFE (2017)
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
Inger Van Steenoven et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations
Ahmad A. Khundakar et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
Lauren Walker et al.
ACTA NEUROPATHOLOGICA (2015)
Definition of a Bidirectional Activity-Dependent Pathway Involving BDNF and Narp
Abigail Mariga et al.
CELL REPORTS (2015)
Neuroendocrine role for VGF
Jo E. Lewis et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen et al.
ALZHEIMERS & DEMENTIA (2014)
Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
Wiesje M. van der Flier et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies
Elizabeta B. Mukaetova-Ladinska et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Clinical and multimodal biomarker correlates of ADNI neuropathological findings
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Early Visuospatial Deficits Predict the Occurrence of Visual Hallucinations in Autopsy-Confirmed Dementia With Lewy Bodies
Joanne M. Hamilton et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2012)
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia
Walter J. Schulz-Schaeffer
ACTA NEUROPATHOLOGICA (2010)
α-synuclein induced synapse damage is enhanced by amyloid-β1-42
Clive Bate et al.
MOLECULAR NEURODEGENERATION (2010)
Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons
Michael C. Chang et al.
NATURE NEUROSCIENCE (2010)
Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies
Michael L. Kramer et al.
JOURNAL OF NEUROSCIENCE (2007)
Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity
DS Xu et al.
NEURON (2003)
Share Paper
